Nancy Freda Smith insider trades

Open-market stock purchases and sales by Nancy Freda Smith, Director at Tempest Therapeutics, Inc, from SEC Form 4 filings since May 15, 2024.

Recent trades

DateStockTradeValue
Sep 22, 2026TPST Tempest Therapeutics, IncBought (not open market)—

Companies traded

  • TPST Tempest Therapeutics, Inc: other filings, last Sep 22, 2026
  • CHUY Chuy's Holdings, Inc: other filings, last Oct 11, 2024

Get free alerts when Nancy Freda Smith files a new trade →